Detalles de la búsqueda
1.
Darapladib for preventing ischemic events in stable coronary heart disease.
N Engl J Med
; 370(18): 1702-11, 2014 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24678955
2.
Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS-AMI trial.
Catheter Cardiovasc Interv
; 85(3): 359-68, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25115966
3.
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
Lancet
; 381(9860): 29-39, 2013 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23141816
4.
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.
Eur Heart J
; 34(11): 835-43, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23293303
5.
Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan.
J Card Fail
; 19(6): 390-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23743487
6.
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial.
Heart Fail Rev
; 17(3): 485-509, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21932146
7.
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.
Eur Heart J
; 32(20): 2563-72, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21785107
8.
First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention.
Circulation
; 122(6): 614-22, 2010 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20660806
9.
Facilitated PCI in patients with ST-elevation myocardial infarction.
N Engl J Med
; 358(21): 2205-17, 2008 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-18499565
10.
Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) trials.
Am Heart J
; 161(6): 1067-72, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21641352
11.
Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) Initiative.
Catheter Cardiovasc Interv
; 75(2): 145-52, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20095009
12.
Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction.
Am J Ther
; 17(4): e78-87, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20634650
13.
Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial.
Eur Heart J
; 30(13): 1666-73, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19411662
14.
Effects of tolvaptan on dyspnoea relief from the EVEREST trials.
Eur Heart J
; 30(18): 2233-40, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19561338
15.
[Evolution of acute myocardial infarction treatment in Argentina from 1987 to 2005]. / Evolución del tratamiento del infarto agudo de miocardio en la Argentina desde 1987 a 2005.
Medicina (B Aires)
; 70(1): 15-22, 2010.
Artículo
en Español
| MEDLINE | ID: mdl-20228019
16.
Effects of overexpansion on stents' recoil, symmetry/asymmetry, and neointimal hyperplasia in aortas of hypercholesterolemic rabbits.
Cardiovasc Pathol
; 17(5): 289-96, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18402820
17.
Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction.
JAMA
; 299(22): 2656-66, 2008 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-18544725
18.
Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR).
Am J Cardiol
; 99(3): 357-63, 2007 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17261398
19.
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
JAMA
; 297(12): 1319-31, 2007 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-17384437
20.
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
JAMA
; 297(12): 1332-43, 2007 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-17384438